OIM
LXRX icon

Oracle Investment Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Oracle Investment Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-33,868
Closed -$216K – 29
2014
Q4 		$216K Buy
+33,868
New +$273K 0.03% 28

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Oracle Investment Management's LXRX Position: Q1 2015 in Review

Oracle Investment Management sold out of Lexicon Pharmaceuticals (LXRX) in Q1 2015, closing a stake of 33,868 shares — an estimated $216K sold.

Oracle Investment Management first reported a position in LXRX in Q4 2014 and held it in 1 quarter. The position peaked at $216K in Q4 2014. 119 funds tracked by Wall St. Rank hold LXRX as of Q1 2015.

  • Oracle Investment Management reported no remaining Lexicon Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • Oracle Investment Management sold 33,868 Lexicon Pharmaceuticals shares in Q1 2015, an estimated $216K.
  • Oracle Investment Management first reported a position in Lexicon Pharmaceuticals in Q4 2014 and held it in 1 quarter.
  • Oracle Investment Management's Lexicon Pharmaceuticals position peaked at $216K in Q4 2014.
  • 119 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2015.

Based on Oracle Investment Management's 13F filing for Q1 2015, filed 15 May 2015.